- Biomay is an FDA inspected and fully integrated CDMO based in Vienna, Austria. Biomay offers GMP manufacturing services for innovative biopharmaceuticals like mRNA, DNA templates, circular plasmids and recombinant proteins.
- At our dedicated mRNA Competence Center, we offer end-to-end mRNA manufacturing — either for drug substance or for finally formulated lipid nanoparticles (LNPs). Biomay’s production scales range from milligram to 100 gram final product.
- Recently, Biomay launched mRNA-encoded spCas9 as a catalog product. Our optimized Cas9 mRNA portfolio features multiple formats with distinct 5′ caps, poly(A) lengths, and nucleoside modifications, tailored for genome editing applications like TCR-T and CAR-T.
- Biomay has extensive expertise in manufacturing large nucleic acid constructs, including pDNA up to 20 kbp and saRNA of more than 12 kb. The company also offers personalized manufacturing for patient-specific medicines, with a facility capacity for up to eight parallel batches.
- Our membership in the Alliance for mRNA Medicines underscores our commitment to innovation and quality in the mRNA field.